$GWH
ESS Tech, Inc. Stock $gwh

$gwh Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000162828023016924 Filed on May 10, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$2.827M	$372.0K	$0.00
YoY Change	312.1%
Cost Of Revenue	$0.00	$0.00
YoY Change
Gross Profit	$2.827M	$372.0K
YoY Change
Gross Profit Margin	100.0%	100.0%
Selling, General & Admin	$7.584M	$7.139M	$9.290M
YoY Change	-12.8%	-23.15%	252.96%
% of Gross Profit	268.27%	1919.09%
Research & Development	$19.45M	$17.73M	$12.90M
YoY Change	20.32%	37.48%	128.2%
% of Gross Profit	688.01%	4766.67%
Depreciation & Amortization	$1.000M	$1.077M	$196.0K
YoY Change	283.14%	449.49%	50.77%
% of Gross Profit	35.37%	289.52%
Operating Expenses	$27.03M	$24.87M	$22.19M
YoY Change	8.74%	12.09%	167.84%
Operating Profit	-$24.21M	-$24.50M	-$22.19M
YoY Change	0.13%	10.42%	167.84%
Interest Expense	$1.220M	$1.252M	$29.00K
YoY Change	78.1%	4217.24%	-49.12%
% of Operating Profit
Other Income/Expense, Net	$1.278M	$2.598M	$16.48M
YoY Change	-85.12%	-84.23%	-111.24%
Pretax Income	-$22.93M	-$21.90M	-$5.709M
YoY Change	47.1%	283.62%	-161.79%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$22.93M	-$21.90M	-$5.709M
YoY Change	47.09%	283.62%	-96.31%
Net Earnings / Revenue	-811.07%	-5887.37%
Basic Earnings Per Share	-$0.15	-$0.14	-$0.04
Diluted Earnings Per Share	-$0.15	-$0.14	-$0.04
COMMON SHARES
Basic Shares Outstanding	154.4M shares	154.3M shares	151.7M shares
Diluted Shares Outstanding	154.9M shares	154.1M shares	151.7M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$99.50M	$119.0M	$212.3M
YoY Change	-48.22%	-43.95%	66253.44%
Cash & Equivalents	$30.29M	$87.81M	$212.3M
Short-Term Investments	$69.20M	$31.20M
Other Short-Term Assets	$4.400M	$5.365M	$5.573M
YoY Change	-5.64%	-3.73%	2222.08%
Inventory
Prepaid Expenses
Receivables	$1.393M	$689.0K	$2.928M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$105.4M	$125.1M	$220.8M
YoY Change	-47.13%	-43.37%	38642.46%
LONG-TERM ASSETS
Property, Plant & Equipment	$18.48M	$18.37M	$10.06M
YoY Change	48.33%	82.71%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$115.0K	$239.0K	$261.0K
YoY Change	-50.85%	-8.43%	-99.9%
Total Long-Term Assets	$22.34M	$22.39M	$14.65M
YoY Change	33.37%	52.81%	-94.14%
TOTAL ASSETS
Total Short-Term Assets	$105.4M	$125.1M	$220.8M
Total Long-Term Assets	$22.34M	$22.39M	$14.65M
Total Assets	$127.8M	$147.5M	$235.5M
YoY Change	-40.89%	-37.38%	-6.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.838M	$2.699M	$1.745M
YoY Change	97.77%	54.67%	4262.5%
Accrued Expenses	$15.00M	$12.57M	$6.598M
YoY Change	50.62%	90.54%	3781.18%
Deferred Revenue	$3.200M	$5.929M	$6.859M
YoY Change	-52.96%	-13.56%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.127M	$1.522M	$1.817M
YoY Change	-60.15%	-16.24%
Total Short-Term Liabilities	$22.71M	$23.02M	$18.35M
YoY Change	3.14%	25.48%	8239.09%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$1.483M
YoY Change		-100.0%
Other Long-Term Liabilities	$0.00	$80.00K	$101.0K
YoY Change	-100.0%	-20.79%	-99.51%
Total Long-Term Liabilities	$0.00	$80.00K	$1.584M
YoY Change	-100.0%	-94.95%	-92.32%
TOTAL LIABILITIES
Total Short-Term Liabilities	$22.71M	$23.02M	$18.35M
Total Long-Term Liabilities	$0.00	$80.00K	$1.584M
Total Liabilities	$30.46M	$30.22M	$36.04M
YoY Change	4.05%	-16.15%	72.91%
SHAREHOLDERS EQUITY
Retained Earnings	-$663.4M	-$640.5M	-$546.3M
YoY Change	18.06%	17.24%	-11028.28%
Common Stock	$16.00K	$16.00K	$16.00K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$97.30M	$117.2M	$199.4M
YoY Change
Total Liabilities & Shareholders Equity	$127.8M	$147.5M	$235.5M
YoY Change	-40.89%	-37.38%	-6.06%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$22.93M	-$21.90M	-$5.709M
YoY Change	47.09%	283.62%	-96.31%
Depreciation, Depletion And Amortization	$1.000M	$1.077M	$196.0K
YoY Change	283.14%	449.49%	50.77%
Cash From Operating Activities	-$19.02M	-$18.51M	-$19.37M
YoY Change	25.47%	-4.46%	198.84%
INVESTING ACTIVITIES
Capital Expenditures	$830.0K	$2.610M	$4.041M
YoY Change	-118.77%	-35.41%	2938.35%
Acquisitions
YoY Change
Other Investing Activities	-$37.31M	$74.67M
YoY Change	-53.13%
Cash From Investing Activities	-$38.14M	$72.06M	-$4.041M
YoY Change	-54.61%	-1883.17%	2938.35%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-140.0K	-$303.0K	-$3.244M
YoY Change	-68.4%	-90.66%	-127.31%
NET CHANGE
Cash From Operating Activities	-19.02M	-$18.51M	-$19.37M
Cash From Investing Activities	-38.14M	$72.06M	-$4.041M
Cash From Financing Activities	-140.0K	-$303.0K	-$3.244M
Net Change In Cash	-57.30M	$53.25M	-$26.66M
YoY Change	-42.48%	-299.73%	-606.63%
FREE CASH FLOW
Cash From Operating Activities	-$19.02M	-$18.51M	-$19.37M
Capital Expenditures	$830.0K	$2.610M	$4.041M
Free Cash Flow	-$19.85M	-$21.12M	-$23.42M
YoY Change	84.87%	-9.8%	253.91%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001819438
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-39525
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	ESS Tech, Inc.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1550150
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	26440 SW Parkway Ave.
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Bldg. 83
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Wilsonville
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	OR
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	97070
CY2023Q1	dei	City Area Code CityAreaCode	855
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	423-9920
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	154366717	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	87811000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	34767000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1413000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1213000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	689000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4952000	usd
CY2023Q1	us-gaap	Trading Securities Debt TradingSecuritiesDebt	31196000	usd
CY2022Q4	us-gaap	Trading Securities Debt TradingSecuritiesDebt	105047000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3952000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5657000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	125061000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	151636000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	18373000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	17570000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3102000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3401000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	676000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	675000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	239000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	271000	usd
CY2023Q1	us-gaap	Assets Assets	147451000	usd
CY2022Q4	us-gaap	Assets Assets	173553000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2699000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3036000	usd
CY2023Q1	ghw	Accrued Liabilities And Other Current Liabilities AccruedLiabilitiesAndOtherCurrentLiabilities	8533000	usd
CY2022Q4	ghw	Accrued Liabilities And Other Current Liabilities AccruedLiabilitiesAndOtherCurrentLiabilities	14125000	usd
CY2023Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	2874000	usd
CY2022Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1643000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1464000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1421000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	5929000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	6168000	usd
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent	1522000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	1600000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	23021000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	27993000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	315000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2151000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2535000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	2442000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	2442000	usd
CY2023Q1	ghw	Common Stock Warrant Liabilities CommonStockWarrantLiabilities	2521000	usd
CY2022Q4	ghw	Common Stock Warrant Liabilities CommonStockWarrantLiabilities	3209000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	80000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	85000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	30215000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	36579000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	154344930	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	154344930	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	153821339	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	153821339	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	16000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	16000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	757700000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	755537000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-640480000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-618579000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	117236000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	136974000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	147451000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	173553000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	372000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	0	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	17732000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12898000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1852000	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1501000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5287000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7789000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	24871000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	22188000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-24499000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-22188000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1252000	usd
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-29000	usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-688000	usd
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-16504000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	658000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2598000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	16479000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-21901000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-21901000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5709000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-5709000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	154123911	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	154123911	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	151683819	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	151683819	shares
CY2021Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	205159000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	47000	usd
CY2022Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	2808000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2760000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-5709000	usd
CY2022Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2022Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	199449000	usd
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	136974000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	104000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2059000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-21901000	usd
CY2023Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2023Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	117236000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-21901000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-5709000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1077000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	196000	usd
CY2023Q1	ghw	Non Cash Interest Income Expense NonCashInterestIncomeExpense	-762000	usd
CY2022Q1	ghw	Non Cash Interest Income Expense NonCashInterestIncomeExpense	14000	usd
CY2023Q1	ghw	Noncash Operating Lease Expense NoncashOperatingLeaseExpense	299000	usd
CY2022Q1	ghw	Noncash Operating Lease Expense NoncashOperatingLeaseExpense	275000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2059000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2760000	usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-688000	usd
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-16504000	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	48000	usd
CY2022Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	0	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-4330000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-785000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1731000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-405000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-529000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1852000	usd
CY2023Q1	ghw	Increase Decrease In Accrued Liabilities And Other Current Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities	-4657000	usd
CY2022Q1	ghw	Increase Decrease In Accrued Liabilities And Other Current Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities	421000	usd
CY2023Q1	ghw	Increase Decrease In Product Warranty Accrual IncreaseDecreaseInProductWarrantyAccrual	1231000	usd
CY2022Q1	ghw	Increase Decrease In Product Warranty Accrual IncreaseDecreaseInProductWarrantyAccrual	0	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-306000	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	0	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-346000	usd
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-165000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-18510000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-19374000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2610000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4041000	usd
CY2023Q1	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	-74668000	usd
CY2022Q1	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	72058000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4041000	usd
CY2023Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	400000	usd
CY2022Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	483000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	104000	usd
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	47000	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2808000	usd
CY2023Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-7000	usd
CY2022Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-303000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3244000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	53245000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-26659000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	36655000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	240232000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	89900000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	213573000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	413000	usd
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	403000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	623000	usd
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2235000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	4534000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	123000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	87811000	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	212331000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1413000	usd
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1167000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	676000	usd
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	75000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	89900000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	213573000	usd
CY2023Q1	ghw	Battery Flexible Energy Capacity Minimum BatteryFlexibleEnergyCapacityMinimum	4	h
CY2023Q1	ghw	Battery Lifespan Number Of Cycles BatteryLifespanNumberOfCycles	20000	cycle
CY2023Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—Certain prior year amounts have been reclassified to conform with current year presentation. These reclassifications had no effect on the reported results of operations.</span>
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	Use of Estimates—The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities and disclosure of commitments and contingencies as of the date of the condensed consolidated financial statements and the reported amounts of expenses during the reporting periods. Such estimates relate to, among others, the useful lives and assessment of recoverability of property and equipment, deferred tax assets valuation, determination of the fair value of the Company’s investments, earnout warrant liabilities, public warrants and private warrants and the determination of variable consideration, standalone selling prices, product warranty liabilities, as well as other accruals. These estimates are based on historical trends, market pricing, current events and other relevant assumptions and data points. Actual results could differ from those estimates and such differences may be material to the condensed consolidated financial statements.
CY2023Q1	us-gaap	Debt Securities Trading Gain Loss DebtSecuritiesTradingGainLoss	5000	usd
CY2022Q1	us-gaap	Debt Securities Trading Gain Loss DebtSecuritiesTradingGainLoss	0	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	154123911	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	151683819	shares
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-21901000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-21901000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-5709000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5709000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	154123911	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	151683819	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	26285501	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	19802308	shares
CY2023Q1	us-gaap	Prepaid Insurance PrepaidInsurance	1669000	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	2033000	usd
CY2023Q1	us-gaap	Supplies Supplies	1716000	usd
CY2022Q4	us-gaap	Supplies Supplies	3147000	usd
CY2023Q1	ghw	Other Prepaid Expense And Other Assets Current OtherPrepaidExpenseAndOtherAssetsCurrent	567000	usd
CY2022Q4	ghw	Other Prepaid Expense And Other Assets Current OtherPrepaidExpenseAndOtherAssetsCurrent	477000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3952000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5657000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	22285000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	20411000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3912000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2841000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	18373000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	17570000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	1071000	usd
CY2022Q1	us-gaap	Depreciation Depreciation	196000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2580000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2948000	usd
CY2023Q1	ghw	Materials And Related Purchases Current MaterialsAndRelatedPurchasesCurrent	3515000	usd
CY2022Q4	ghw	Materials And Related Purchases Current MaterialsAndRelatedPurchasesCurrent	6892000	usd
CY2023Q1	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	1014000	usd
CY2022Q4	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	770000	usd
CY2023Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	935000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1011000	usd
CY2023Q1	ghw	Accrued Capital Expenditures AccruedCapitalExpenditures	190000	usd
CY2022Q4	ghw	Accrued Capital Expenditures AccruedCapitalExpenditures	1093000	usd
CY2023Q1	ghw	Other Accrued Liability And Other Liabilities Current OtherAccruedLiabilityAndOtherLiabilitiesCurrent	299000	usd
CY2022Q4	ghw	Other Accrued Liability And Other Liabilities Current OtherAccruedLiabilityAndOtherLiabilitiesCurrent	1411000	usd
CY2023Q1	ghw	Accrued Liabilities And Other Current Liabilities AccruedLiabilitiesAndOtherCurrentLiabilities	8533000	usd
CY2022Q4	ghw	Accrued Liabilities And Other Current Liabilities AccruedLiabilitiesAndOtherCurrentLiabilities	14125000	usd
CY2022Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1643000	usd
CY2021Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	0	usd
CY2023Q1	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	1504000	usd
CY2022Q1	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	0	usd
CY2023Q1	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	273000	usd
CY2022Q1	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	0	usd
CY2023Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	2874000	usd
CY2022Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	0	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	1522000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	1915000	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	1522000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1600000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	315000	usd
CY2023Q1	us-gaap	Certificates Of Deposit At Carrying Value CertificatesOfDepositAtCarryingValue	75000	usd
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	11461227	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	11461227	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	11461227	shares
CY2023Q1	ghw	Class Of Warrant Or Right Grants In Period ClassOfWarrantOrRightGrantsInPeriod	0	shares
CY2023Q1	ghw	Class Of Warrant Or Right Exercises In Period ClassOfWarrantOrRightExercisesInPeriod	0	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	11461227	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	11461247	shares
CY2022Q1	ghw	Class Of Warrant Or Right Grants In Period ClassOfWarrantOrRightGrantsInPeriod	0	shares
CY2022Q1	ghw	Class Of Warrant Or Right Exercises In Period ClassOfWarrantOrRightExercisesInPeriod	20	shares
CY2022Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	11461227	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	12500	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	12500	shares
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2059000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2760000	usd
CY2023Q1	ghw	Share Based Compensation Arrangement By Share Based Payment Awards Potential Increase In Shares Authorized Percentage Of Shares Outstanding ShareBasedCompensationArrangementByShareBasedPaymentAwardsPotentialIncreaseInSharesAuthorizedPercentageOfSharesOutstanding	0.05
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P3Y
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3223109	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.01
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y4M20D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	4583000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	300501	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.17
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	186813	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.51
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2735795	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.12
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y29D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2428000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	1947123	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	0.76
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P7Y21D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	3244000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	1811938	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	0.86
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P6Y9M7D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	1710000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	31014000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y2M19D
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	372000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	0	usd
CY2023Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	76000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	11000	usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	8371000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	8610000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	65000	usd
CY2023Q1	ghw	Contract With Customer Liability Period Change ContractWithCustomerLiabilityPeriodChange	-239000	usd
CY2023Q1	ghw	Contract With Customer Liability Advance Payment ContractWithCustomerLiabilityAdvancePayment	370000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	372000	usd
CY2023Q1	ghw	Contract With Customer Liability Deposits Returned To Customers ContractWithCustomerLiabilityDepositsReturnedToCustomers	58000	usd
CY2023Q1	ghw	Contract With Customer Liability Change In Estimate Of Variable Consideration ContractWithCustomerLiabilityChangeInEstimateOfVariableConsideration	244000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	5929000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	2442000	usd

Files In Submission

Name	View Source	Status
0001628280-23-016924-index-headers.html	Edgar Link	pending
0001628280-23-016924-index.html	Edgar Link	pending
0001628280-23-016924.txt	Edgar Link	pending
0001628280-23-016924-xbrl.zip	Edgar Link	pending
exhibit311-ceocertq12023.htm	Edgar Link	pending
exhibit312-cfocertq12023.htm	Edgar Link	pending
exhibit321-ceocertq12023.htm	Edgar Link	pending
exhibit322-cfocertq12023.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
ghw-20230331.htm	Edgar Link	pending
ghw-20230331.xsd	Edgar Link	pending
ghw-20230331_g1.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
ghw-20230331_cal.xml	Edgar Link	unprocessable
ghw-20230331_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ghw-20230331_pre.xml	Edgar Link	unprocessable
ghw-20230331_lab.xml	Edgar Link	unprocessable
ghw-20230331_htm.xml	Edgar Link	completed
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GWH
ESS Tech, Inc. Stock $gwh

2023 Q2 Form 10-Q Financial Statement

#000162828023016924 Filed on May 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GWH ESS Tech, Inc. Stock $gwh

2023 Q2 Form 10-Q Financial Statement

#000162828023016924 Filed on May 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GWH
ESS Tech, Inc. Stock $gwh